
Analyst Julian Harrison of BTIG reiterated a Buy rating on Abivax SA Sponsored ADR, retaining the price target of $175.00. Julian Harrison has given his Buy rating due to a
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| ABVX | Abivax SA Sponsored ADR | 82.10 | -31.73 | -27.87% |
| Name | Price | % Change | |
|---|---|---|---|
| $82.10 | -27.87% |

Analyst Julian Harrison of BTIG reiterated a Buy rating on Abivax SA Sponsored ADR, retaining the price target of $175.00. Julian Harrison has given his Buy rating due to a

The major averages were mixed near noon, with the Dow falling almost 300 points but the Nasdaq climbing nearly 100 points as oil prices eased fractionally following yesterday’s sharp decline.

Wedbush lowered the firm’s price target on Abivax (ABVX) to $118 from $140 and keeps a Neutral rating on the shares. The firm notes the company reported Q2/first half of

Truist lowered the firm’s price target on Abivax (ABVX) to $151 from $155 and keeps a Buy rating on the shares. The firm is updating its model while noting that

Fabio Cataldi, M.D., Chief Medical Officer, will be leaving Abivax (ABVX) in Q4. Chris Rabbat, Ph.D., who has led Global Medical Affairs since 2023, will succeed Cataldi as Chief Medical

Pre-earnings options volume in Abivax (ABVX) is normal with calls leading puts 10:9. Implied volatility suggests the market is anticipating a move near 6.0%, or $6.21, after results are released.

Abivax SA Sponsored ADR (ABVX) is scheduled to report 2nd quarter earnings on 09/21/2026. Regarding Q2 estimates, Wall Street analysts expect Abivax SA Sponsored ADR to post earnings of -$0.92

Abivax ($ABVX) stock was down 2.43% on Friday ahead of the French pharmaceutical company’s upcoming earnings report. The company is set to release its Q2 2026 earnings during market hours

Unusual total active option classes on open include: ADT (ADT), Carnival (CCL), AGNC Investment Corp. (AGNC), Fly Leasing Ltd (FLY), Abivax (ABVX), Churchill Capital Corp X (INFQ), Cipher Mining (CIFR),

Goldman Sachs initiated coverage of Abivax (ABVX) with a Buy rating and $155 price target Key pipeline asset obefazimod is “uniquely positioned” and differentiated in a competitive market, offering biologic-like
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Reiterated | Oct 21, 2026 | ||||
| buy | Reiterated | Oct 20, 2026 | ||||
| buy | Reiterated | Oct 20, 2026 | ||||
| buy | Reiterated | Oct 1, 2026 | ||||
| buy | Reiterated | Sep 28, 2026 | ||||
| buy | Reiterated | Sep 22, 2026 | ||||
| buy | Reiterated | Sep 22, 2026 | ||||
| hold | Reiterated | Sep 22, 2026 | ||||
| buy | Initiated | Sep 9, 2026 | ||||
| buy | Upgraded | Jul 1, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Dec 14, 2026TBA | $7.40B | $-0.92 | $923.00K | -0.37 | -16.33 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.